PH vs RCUS · P/E 28, rev $19.85B vs rev $258.0M
Parker-Hannifin Corporation (PH) versus Arcus Biosciences Inc (RCUS) — a side-by-side from cached financials, not a winner call.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Arcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Latest reported RCUS revenue for 2024-12-31 was $258.0M. Net income was -$283.0M. Revenue was up 120.5% from 2023-12-31 to 2024-12-31. RCUS currently screens at market cap $885.2M.
PH currently screens at market cap $91.89B and trailing P/E 27.7. RCUS currently screens at market cap $885.2M.
Not investment advice. Open the PH and RCUS stock pages for the full models.
Not investment advice.